[{"Assets_0_Q2_USD":145526000.0,"CommonStockSharesOutstanding_0_Q2_shares":34433000.0,"EarningsPerShareBasic_2_Q2_USD":-0.07,"EarningsPerShareBasic_1_Q2_USD":-0.1,"EarningsPerShareDiluted_2_Q2_USD":-0.07,"EarningsPerShareDiluted_1_Q2_USD":-0.1,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":6638000.0,"NetIncomeLoss_2_Q2_USD":-2423000.0,"NetIncomeLoss_1_Q2_USD":-3301000.0,"StockholdersEquity_0_Q2_USD":125934000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":34234000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":34322000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":34234000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":34322000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20170807"}]